Cartesian Therapeutics, Inc. RNAC
6.73 USD -0.05 (-0.74%)
Nov 6, 2026, 9:44 AM EST
6.73 Day range 6.82
5.60 52-week range 11.00
- YTD
- -6.66%
- 1 year
- -12.26%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 2.80M | 38.91M | 26.00M | 110.78M | 85.08M | |
| 2.80M | 38.91M | 26.00M | 110.78M | 85.08M | |
| -143.41M | -43.90M | -86.42M | 14.54M | -4.60M | |
| -130.30M | -77.42M | -219.71M | 35.38M | -25.69M | |
| -5.02 | -4.49 | -49.76 | 3.00 | -6.60 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 125.14M | 212.61M | 76.91M | 106.44M | 114.06M | |
| 296.41M | 435.02M | 305.05M | 165.89M | 159.88M | |
| 422.65M | 441.82M | 444.68M | 72.06M | 137.36M | |
| 12.68M | 13.98M | 10.96M | 37.92M | 35.28M | |
| -126.24M | -6.80M | -440.18M | 93.83M | 22.52M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -73.94M | -23.67M | -51.16M | -31.63M | -60.38M | |
| -5.45M | -8.74M | 34.61M | -15.00M | -17.14M | |
| -8.05M | 168.43M | -13.14M | 39.22M | 52.90M | |
| -5.45M | -8.74M | -206.00K | -1.20M | -1.08M | |
| -87.41M | 135.99M | -29.75M | -7.40M | -24.63M |